ELECTRONIC ARTICLE |



* Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts
Division of Newborn Medicine, Department of Pediatrics, MassGeneral Hospital for Children, Boston, Massachusetts
Patient Care Services, MassGeneral Hospital for Children, Boston, Massachusetts
Maternal use of the antispasmodic baclofen during pregnancy is an uncommon clinical scenario and leads to uncertainty regarding neonatal risks. We present a team-based, peripartum management plan designed for safe monitoring and minimizing the risk of neonatal withdrawal after unusual drug exposure. Incorporating the expertise of neonatology, nursing, pharmacy, neurology, and the lactation service, as well as parental input, this consensus approach was implemented in a case of maternal oral baclofen use with a successful outcome for the infant and family.
Key Words: baclofen pregnancy neonate withdrawal multidisciplinary
Abbreviations: GABA,
-aminobutyric acid AAP, American Academy of Pediatrics